Dr. Shore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1260 silas deane hwy
Wethersfield, CT 06109Phone+1 860-547-1876Fax+1 860-520-1379
Summary
- Dr. Eric Shore is a pulmonologist in Hartford, CT and is affiliated with Hartford Hospital. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 40 years. He specializes in asthma & copd, interstitial lung diseases, and thoracic oncology and is experienced in critical care medicine. He has more than 30 publications and over 500 citings.
Education & Training
- Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1984
- Temple University HospitalResidency, Internal Medicine, 1977 - 1981
- Perelman School of Medicine at the University of PennsylvaniaClass of 1977
Certifications & Licensure
- CT State Medical License 1984 - 2025
- PA State Medical License 1979 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2021
- quality and safety award Hartford hospital Board of Directors, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsTreatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltrationJoseph L. Kuti, Islam M. Ghazi, Richard Quintiliani, Eric Shore, David P. Nicolau
International Journal of Antimicrobial Agents. 2016-09-01 - The High (Personal) Cost of Critical Care Medicine.Eric Shore
Connecticut Medicine. 2016-09-01 - 72 citationsPhase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.Kevin P. Connors, Seth T. Housman, J. Samuel Pope, John Russomanno, Edward Salerno
Antimicrobial Agents and Chemotherapy. 2014-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: